Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
Katharina Lankes(Technical University of Munich), Matthias Wirth(Humboldt-Universität zu Berlin)
Cited by 23
Related Papers
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
|Nucleic Acids Research|2014|64